Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.

By
Carlos Quezada Ruiz, MD
July 15, 2026
2 min

Retinal Physician

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

#1

Bascom Palmer Eye Institute

Miami, Florida
Key Differentiators
- Inherited Retinal Diseases
- Ophthalmology
#2

Wilmer Eye Institute, Johns Hopkins Medicine

Baltimore, Maryland
Key Differentiators
- Inherited Retinal Diseases
- Ophthalmology
#3

Retina Consultants of Texas

Dallas, Texas
Key Differentiators
- Retina
- Ophthalmology
#4

Retina-Vitreous Associates Medical Group

Los Angeles, California
Key Differentiators
- Retina
- Ophthalmology
#5

Vitreoretinal Consultants of New York

New York, New York
Key Differentiators
- Retina
- Ophthalmology